Company news

Chimeric Therapeutics Limited TEMP news

Latest news releases, newest first.

Quarterly Activities/Appendix 4C Cash Flow Report

April 29, 2026

CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi

April 26, 2026